SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.





3D Nasal Cast Model
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
Proprietary Nasal Drug Delivery System
SNBL has developed a proprietary nasal drug delivery technology, μco™ System, consisting of a powder carrier technology (μco™ Carrier) designed for increased drug absorption through its
muco-adhesive properties and a delivery device technology designed for simple use, and complete and consistent delivery of intranasal powder formulations.
Our technology can be applied to a wide range of drugs, including small molecules, peptides, and biologics. It can be utilized for improved systemic drug absorption, enhanced
muco-immunity for a vaccine, or for enabling drug delivery to the brain through the olfactory area.
The μco™ System is a nasal drug delivery platform comprised of powder carrier technology and delivery device technology.
*GRAS: Generally Recognized as Safe: The U.S. Food and Drug Administration (FDA) designation that a chemical or substance added to food is generally recognized to be safe.
Special analyses for the development of our nasal drug delivery technology